London Stock Exchange · Healthcare
Invest in Proteome Sciences stock from India
Indian and foreign residents can buy Proteome Sciences (PRM) shares directly through Paasa.
By Paasa · Updated
Proteome Sciences at a glance
- Price
- £0.01+£0.00 (3.93%)
- Market cap
- £4.20M
- Day range
- £0.01 – £0.02
- P/E
- -1.99
- Dividend yield
- None
- Volume
- 536.00
- 1 month
- -6.13%
- 6 months
- -9.63%
- YTD
- -41.80%
- 1 year
- -20.92%
- 5 years
- -72.80%
Proteome Sciences statements, FY2021–FY2025
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | £3.8M | £4.9M | £5.0M | £7.8M | £5.1M |
| Gross profit | −£1.0M | −£167.0K | £1.2M | £4.8M | £3.0M |
| Operating income | −£2.7M | −£2.3M | −£1.5M | £1.5M | £512.0K |
| Net income | −£3.1M | −£3.4M | −£2.4M | £1.3M | £72.0K |
| Earnings per share | −£0.01 | −£0.01 | −£0.01 | £0.00 | £0.00 |
| EBITDA | −£1.7M | −£1.5M | −£1.1M | £2.1M | £625.0K |
| Total assets | £8.3M | £9.2M | £11.5M | £12.4M | £10.0M |
| Total debt | £15.8M | £14.5M | £13.5M | £11.9M | £11.7M |
| Cash and short-term investments | £781.0K | £1.1M | £2.0M | £4.0M | £2.4M |
| Shareholders' equity | −£9.5M | −£6.5M | −£3.1M | −£843.0K | −£2.8M |
| Operating cash flow | −£46.0K | −£826.0K | −£481.0K | £3.9B | £10.5B |
| Free cash flow | −£143.0K | −£1.1M | −£718.0K | £2.1B | £8.8B |
| Capital expenditure | −£97.0K | −£224.0K | −£237.0K | −£1.7B | −£1.7B |
Fiscal years as reported, the latest ending 31 Dec 2025. Figures in GBP; a dash means the provider reported nothing for that line.
Peer comparison
| Company | Ticker | Price | Market cap |
|---|---|---|---|
| Genedrive | GDR.L | £0.01 | £1.89B |
| Tissue Regenix | TRX.L | £0.07 | £516.45M |
| MyHealthChecked | MHC.L | £0.09 | £455.31M |
| N4 Pharma | N4P.L | £0.00 | £395.33M |
| Theracryf | TCF.L | £0.00 | £376.07M |
| Surgical Innovations | SUN.L | £0.00 | £373.13M |
| CRISM Therapeutics | CRTX.L | £0.10 | £365.75M |
| CelLBxHealth | AGL.L | £0.01 | £296.73M |
Peers as grouped by the data provider. This is not an investment recommendation.
How to invest in Proteome Sciences from India
Step 1
Open your Paasa account
KYC takes a few minutes: PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Step 2
Add funds from your Indian bank account
Remit up to $250,000 a year under the RBI's Liberalised Remittance Scheme. Your bank converts the rupees to US dollars at its rate on the day you remit, and Interactive Brokers converts the dollars to GBP when you buy.
Step 3
Search PRM and buy
Find Proteome Sciences by name or by its ticker, PRM, and place your order.
Why invest in Proteome Sciences from India
What Proteome Sciences does
Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant that provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator which analyzes where… Proteome Sciences operates in the Medical - Specialties industry within the Healthcare sector.
Paasa handles the paperwork
Investing abroad brings paperwork with it: remittance filings, capital gains reporting, foreign asset disclosure. Paasa prepares all of it for you. Your India-ready tax reports arrive at year end, ready to file.
Here's what inheritance rules in the UK mean for your Proteome Sciences shares.
Shares in UK-incorporated companies are UK-situs assets and fall within UK Inheritance Tax, charged at 40% above the £325,000 threshold for non-residents.
Frequently asked questions
Can I buy Proteome Sciences stock from India?
Yes. Indian residents and NRIs can buy Proteome Sciences (PRM) shares directly through Paasa. Proteome Sciences is listed on the London Stock Exchange, in the Medical - Specialties industry. Your money leaves India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name at Interactive Brokers.
How are Proteome Sciences dividends taxed for Indian investors?
Proteome Sciences does not currently pay a dividend, so there is nothing to withhold or declare today. If it starts paying one, the UK levies 0% withholding tax on company dividends paid to non-residents, and dividends are taxed at your slab rate in India.
What tax do I pay in India when I sell Proteome Sciences shares?
Non-residents are exempt from UK capital gains tax on the disposal of listed shares. In India, gains on shares held for more than 24 months are long-term and taxed at 12.5%, and gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. Both are worked out in rupees at the GBP/INR rate on the day you bought and the day you sold, so the currency move is part of the gain. Paasa's capital-gains statement gives you the figures for your return.
What happens to my Proteome Sciences shares if I pass away?
Shares in UK-incorporated companies are UK-situs assets and fall within UK Inheritance Tax, charged at 40% above the £325,000 threshold for non-residents. The rule looks at everything you hold there, not at Proteome Sciences alone.
Is there stamp duty when I buy Proteome Sciences shares?
The UK charges 0.5% Stamp Duty Reserve Tax when buying direct company shares electronically on the LSE; ETFs and UCITS funds do not attract it.